Table 3.
Metabolic and cardiovascular comorbidities according to COPD severity
| Disease | Stage I N=43 |
Stage II N=167 |
Stage III N=362 |
Stage IV N=294 |
Total N=866 |
|---|---|---|---|---|---|
| Hypertension | 34 (79.1%) | 90 (53.9%) | 200 (55.2%) | 171 (58.2%) | 495 (57.1%) |
| Hypercholesterolemiaa | 24 (55.8%) | 63 (37.7%) | 111 (30.6%) | 90 (30.6%) | 288 (33.2%) |
| Diabetesa | 6 (13.9%) | 42 (25.1%) | 122 (33.7%) | 100 (34.0%) | 270 (31.2%) |
| Heart failurea | 5 (11.6%) | 22 (13.2%) | 86 (23.7%) | 86 (29.2%) | 199 (23.0%) |
| Atrial fibrillationa | 2 (4.6%) | 22 (13.2%) | 68 (18.7%) | 73 (24.8%) | 165 (19.0%) |
| Peripheral vascular disease | 6 (13.9%) | 22 (13.2%) | 68 (18.8%) | 54 (18.3%) | 150 (17.3%) |
| Ischemic heart disease | 10 (23.3%) | 17 (10.2%) | 68 (18.8%) | 47 (15.9) | 142 (16.4%) |
Note:
a
Significant group differences (P<0.05) according to Mantel–Haenszel test.
Abbreviation: COPD, chronic obstructive pulmonary disease.